Literature DB >> 16632355

3-(4-Piperidinyl)indoles and 3-(4-piperidinyl)pyrrolo-[2,3-b]pyridines as ligands for the ORL-1 receptor.

Gilles C Bignan1, Kathleen Battista, Peter J Connolly, Michael J Orsini, Jingchun Liu, Steven A Middleton, Allen B Reitz.   

Abstract

A novel series of indoles and 1H-pyrrolo[2,3-b]pyridines having a piperidine ring at the 3-position were synthesized and found to bind with high affinity to the ORL-1 receptor. Structure-activity relationships at the piperidine nitrogen were investigated in each series. Substitution on the phenyl ring and nitrogen atom of the indole and 1H-pyrrolo[2,3-b]pyridine cores generated several selective high-affinity ligands that were agonists of the ORL-1 receptor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632355     DOI: 10.1016/j.bmcl.2006.03.094

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  In silico study of the structurally similar ORL1 receptor agonist and antagonist pairs reveal possible mechanism of receptor activation.

Authors:  Milan Senćanski; Ljiljana Dosen-Mićović
Journal:  Protein J       Date:  2014-06       Impact factor: 2.371

3.  Panicolytic-like effects caused by substantia nigra pars reticulata pretreatment with low doses of endomorphin-1 and high doses of CTOP or the NOP receptors antagonist JTC-801 in male Rattus norvegicus.

Authors:  Juliana Almeida da Silva; Audrey Franceschi Biagioni; Rafael Carvalho Almada; Renato Leonardo de Freitas; Norberto Cysne Coimbra
Journal:  Psychopharmacology (Berl)       Date:  2017-08-30       Impact factor: 4.530

4.  Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.

Authors:  Pankaj R Daga; Willma E Polgar; Nurulain T Zaveri
Journal:  J Chem Inf Model       Date:  2014-09-17       Impact factor: 4.956

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.